7 Einträge gefunden

1. Return of individual genomic research results within the PRAEGNANT multicenter registry study

   1. Huebner, Hanna
   2. Ruebner, Matthias
   3. Kurbacher, Christian
   4. Hadji, Peyman
   5. Hartkopf, Andreas D
   6. Lux, Michael P
   7. Huober, Jens

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

   1. Huebner, Hanna
   2. Kurbacher, Christian M
   3. Kuesters, Geoffrey
   4. Hartkopf, Andreas D
   5. Lux, Michael P
   6. Huober, Jens
   7. Volz, Bernhard

   2020 - Forschungsinformationssystem des UKE
3. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

   1. Tesch, Hans
   2. Müller, Volkmar
   3. Wöckel, Achim
   4. Ettl, Johannes
   5. Belleville, Erik
   6. Schütz, Florian
   7. Hartkopf, Andreas

   2020 - Forschungsinformationssystem des UKE
4. Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

   1. Lux, Michael P
   2. Nabieva, Naiba
   3. Hartkopf, Andreas D
   4. Huober, Jens
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
5. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry

   1. Hartkopf, Andreas D
   2. Huober, Jens
   3. Volz, Bernhard
   4. Nabieva, Naiba
   5. Taran, Florin-Andrei
   6. Schwitulla, Judith
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
6. Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Loibl, Sibylle
   4. Nekljudova, Valentina
   5. Weber, Karsten E
   6. Huober, Jens
   7. Fehm, Tanja

   2017 - Forschungsinformationssystem des UKE
7. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.

   1. Witzel, Isabell
   2. Loibl, Sibylle
   3. von Minckwitz, Gunter
   4. Mundhenke, Christoph
   5. Huober, Jens
   6. Hanusch, Claus
   7. Henschen, Stephan

   2010 - Forschungsinformationssystem des UKE